Fully-automatic insulin delivery system
ThinPump
NO USER INPUT
A revolutionary solution – fully automated, implantable insulin delivery
  • Portal Diabetes, Inc. is developing the ThinPump™: First fully automated insulin delivery system. 
  • No more carb counting, no more meal announcements, no more sleep interruption.
  • Clear markets need to reduce management burden thereby improving outcomes.
  • An open-loop implantable delivery system was developed by this founding team
  • Closed-loop feasibility is made possible by available CGMs
Why PhysioLogic Devices?

Diabetes is an enormous and growing market lacking an adequate solution.

An implantable artificial pancreas (AP) will functionally cure diabetes.
PhysioLogic’s Plan to Develop the first fully automated insulin delivery device.
Patients, providers, and payers will each greatly benefit from an Implantable AP.
The PhysioLogic team is unique, having previously built all the components of an Implantable AP.
Milestones (?)
1868
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
2016
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
2156
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
About us
PhysioLogic Devices: The ThinPump Artificial Pancreas
Founded by a person who led the engineering development of four different implantable pumps, Pete Lord, PDI is rooted in experience and a patient-driven focus. Leveraging the combined technical and operations talent of Pete's team and recent technology improvements enabling a closed-loop system, Stacy Chambliss brings experience from founding through FDA approval of other class III implantable devices. PDI is uniquely capable of its challenge and privilege in bringing and safe and effective automated implantable pump to patients with type 1 diabetes.
Our Team
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Lorem Ipsum Dolor
CEO
Lorem Ipsum Dolor
CEO
Lorem Ipsum Dolor
CEO
Lorem Ipsum Dolor
CEO
The Challenge
Diabetes | The Elusive Balancing Act
Patients are overwhelmed
  • 24/7 titration with subcutaneous insulin is required with unpredictable outcomes.
  • Skin site management; infections, tape allergies
  • Pump Maintenance
  • Refrigeration of insulin
  • Purchasing insulin and disposable supplies
  • Insurance
Why do 80% of T1D patients fail?
  • 80% of patients fail to achieve the control required to prevent chronic complications, blindness, amputations, and kidney failure
  • Why is glycemic control worsening?
  • Why is nothing changing?
  • Management is too burdensome
The ThinPump will make management of diabetes effortless
Insulin is not delivered to the normal physiologic site.
It’s time for a new approach!
Technology
The Technology
SOLUTION | ThinPump™ Artificial Pancreas
An implantable pump delivers insulin to the intraperitoneal space
ThinPump™ AP | fully automated
A fully autonomous insulin delivery system. A functional cure for diabetes.
Rapid uptake of intraperitoneal insulin enables a basic control algorithm to fully automate insulin delivery.
Compatible continuous glucose sensor that transmits data to the artificial pancreas.
Updates to the fully automated system may be made post-implantation.
ThinPump™ | Lorem Ipsum Dolor
  • Insulin is refilled in the clinic every 3 months 
  • The device is replaced about every 7 years when a new battery is needed
  • Communication with the device is achieved through bluetooth telemetry involving a secure link
  • The pump is similar in size to a hockey puck and is placed under the skin in the abdomen during a brief, outpatient procedure
Intraperitoneal Insulin Delivery
Getting it to the Right Place
Intraperitoneal insulin is delivered to the liver just as it would from a normal pancreas. Restores the Pancreas-Liver partnership.
Intraperitoneal insulin kinetics are 2x faster than subcutaneous
  • Faster “on” means less mealtime hyperglycemia
  • Faster “off” means less hypoglycemia
  • Decreased tissue insulin means reduced glycemic swings
  • Normalizes lipids, growth factor, and testosterone levels.
Controls Blood Sugar Level Continuously
Fully automated: a functional cure for diabetes.
90%+ time in range is achievable without user input: no more carb counting, no more meal or activity announcements, and no more corrections
Time-in-range (a key diabetes metric): 96% to 99% is possible with no user input.
The Platform
Lorem Ipsum Dolor
Image or Video
Lorem ipsum
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Dolor Sit Amet
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Dolor Sit Amet
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard
Lorem ipsum dolor.
Sit amet!